Pineal yolk sac tumor: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Mahshid)
Line 18: Line 18:
*On brain MRI, pineal yolk sac tumor is characterized by hypointensity on T1-weighted images and hyperintensity on T2-weighted images. There may be enhancement after contrast administration.<ref name="pmid17607429">{{cite journal| author=Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF| title=Pineal yolk sac tumor: correlation between neuroimaging and pathological findings. | journal=Arq Neuropsiquiatr | year= 2007 | volume= 65 | issue= 2A | pages= 283-5 | pmid=17607429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17607429  }} </ref>
*On brain MRI, pineal yolk sac tumor is characterized by hypointensity on T1-weighted images and hyperintensity on T2-weighted images. There may be enhancement after contrast administration.<ref name="pmid17607429">{{cite journal| author=Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF| title=Pineal yolk sac tumor: correlation between neuroimaging and pathological findings. | journal=Arq Neuropsiquiatr | year= 2007 | volume= 65 | issue= 2A | pages= 283-5 | pmid=17607429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17607429  }} </ref>
*[[Biopsy]] is generally done to confirm the diagnosis of pineal yolk sac tumor.<ref name="pmid17607429">{{cite journal| author=Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF| title=Pineal yolk sac tumor: correlation between neuroimaging and pathological findings. | journal=Arq Neuropsiquiatr | year= 2007 | volume= 65 | issue= 2A | pages= 283-5 | pmid=17607429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17607429  }} </ref>
*[[Biopsy]] is generally done to confirm the diagnosis of pineal yolk sac tumor.<ref name="pmid17607429">{{cite journal| author=Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF| title=Pineal yolk sac tumor: correlation between neuroimaging and pathological findings. | journal=Arq Neuropsiquiatr | year= 2007 | volume= 65 | issue= 2A | pages= 283-5 | pmid=17607429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17607429  }} </ref>
==Treatment==
*The mainstay of therapy for pineal yolk sac tumor is [[radiotherapy]] and/or [[chemotherapy]]. Sometimes, [[surgical resection]] may be done.<ref name="pmid17607429">{{cite journal| author=Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF| title=Pineal yolk sac tumor: correlation between neuroimaging and pathological findings. | journal=Arq Neuropsiquiatr | year= 2007 | volume= 65 | issue= 2A | pages= 283-5 | pmid=17607429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17607429  }} </ref>
*The mainstay of therapy for pineal yolk sac tumor is [[radiotherapy]] and/or [[chemotherapy]]. Sometimes, [[surgical resection]] may be done.<ref name="pmid17607429">{{cite journal| author=Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF| title=Pineal yolk sac tumor: correlation between neuroimaging and pathological findings. | journal=Arq Neuropsiquiatr | year= 2007 | volume= 65 | issue= 2A | pages= 283-5 | pmid=17607429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17607429  }} </ref>
{| class="wikitable"
|+
! colspan="2" |Management Options of Penial Gland tumors
|-
|'''CSF diversion'''
|
* The optimal surgical strategy to treat acute hydrocephalus in patients with pineal tumors is uncertain.
* CSF diversion (ventriculoperitoneal [VP] shunt or third ventriculostomy may be necessary in symptomatic patients, although debulking surgery may obviate the need for this procedure
* When CSF diversion is necessary, endoscopic third ventriculostomy can be carried out at the same time as the biopsy and is preferred over VP shunts, which can be complicated by infection, shunt malfunction, subdural hematoma, and rarely, tumor seeding
|-
|'''Surgical resection'''
|
* Some series report long-term survival with surgery alone, even in patients with pineoblastomas.
* Indeed, for pineoblastomas, gross total surgical resection appears to correlate with improved survival.
* Patients with symptomatic recurrent pineocytomas should also be considered for surgical resection of the lesion
|-
|'''Radiation'''
|
* Postoperative adjuvant RT is frequently (but not universally) recommended, and local control is dose-dependent.
* The incidence of leptomeningeal recurrence was significantly lower among patients receiving CSI compared with those who did not.
* The five-year survival rates were 86 and 49 percent for pineocytomas and non-pineocytoma PPTs, respectively.
* Adjuvant RT is not universally recommended after gross total resection of a pineocytoma
|-
|'''Stereotactic radiosurgery'''
|
* Stereotactic radiosurgery (SRS) is emerging as a useful treatment alternative for pineocytomas, although experience is limited.
* The precise radiation fields that are defined by MRI or CT-computerized treatment planning minimize damage to the surrounding brain, and the risks of general anesthesia and craniotomy are avoided.
* SRS is increasingly being used to treat pineal region tumors, either as an additional therapy after conventional treatments or as a primary treatment.
* Due to the low rate of side effects, IRS may develop into an attractive alternative to microsurgery in de novo diagnosed pineocytomas. In malignant PPTs, IRS may be routinely applied in a multimodality treatment schedule supplementary to conventional irradiation.
|-
|'''Chemotherapy as part of multimodality therapy'''
|
* The similarity of pineoblastomas to medulloblastomas in terms of their clinical behavior and tendency for leptomeningeal seeding has led to the use of similar chemotherapy regimens in patients with pineoblastoma as part of a multimodality approach.
* Chemotherapy has been used to delay radiation therapy in very young children, for whom the long-term neurocognitive and developmental side effects of craniospinal irradiation (CSI) are a major concern.
* The importance of radiation therapy as a component of the initial treatment of supratentorial primitive neuroectodermal tumors (PNETs) is also supported by the German HIT-SKK87 and HIT-SKK92 protocols, as well as the Canadian pediatric brain tumor protocol
|}


==References==
==References==

Revision as of 04:11, 2 May 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Synonyms and keywords: Pineal yolk sac tumors; Pineal yolk sac tumour; Pineal yolk sac tumours; Pineal endodermal sinus tumor; Pineal endodermal sinus tumors; Pineal endodermal sinus tumour; Pineal endodermal sinus tumours; Pineal yolk sac carcinoma; Pineal yolk sac carcinomas; Pineal gland tumor; Germ cell tumor; Brain tumor

Overview

  • Pineal yolk sac tumor is a rare type of extra gonadal yolk sac tumor. They make up a small fraction of all intracranial germ cell tumors and an even small fraction of pineal masses overall.[1]
  • Pure pineal yolk sac tumors secrete AFP.
  • On microscopic histopathological analysis, pineal yolk sac tumor is characterized by poorly differentiated endothelium-like, cuboidal, or columnar cells with prominent nucleoli and significant mitotic activity.[2]
  • Pineal yolk sac tumor is demonstrated by positivity to tumor markers such as AFP, cytokeratin, and AAT.[3] PAS-diastase positive hyaline globules and Schiller-Duval bodies are the characteristic features of pineal yolk sac tumors.[2]
  • In upto 50% of cases, these tumors co-exist with other germ cell tumors.[4]
  • Pineal yolk sac tumor may be associated with Down syndrome.[5]
  • Common complication of pineal yolk sac tumor includes obstructive hydrocephalus.
  • Prognosis of pineal yolk sac tumor is generally poor.[3]
  • Symptoms of pineal yolk sac tumor include headache, nausea, vomiting, weakness, confusion, and somnolence.[2][3]
  • Head CT scan and brain MRI may be helpful in the diagnosis of pineal yolk sac tumor.
  • On head CT scan, pineal yolk sac tumor is characterized by a hypodense, heterogenous mass in the pineal region with signs of obstructive hydrocephalus.
  • On brain MRI, pineal yolk sac tumor is characterized by hypointensity on T1-weighted images and hyperintensity on T2-weighted images. There may be enhancement after contrast administration.[2]
  • Biopsy is generally done to confirm the diagnosis of pineal yolk sac tumor.[2]


Treatment

Management Options of Penial Gland tumors
CSF diversion
  • The optimal surgical strategy to treat acute hydrocephalus in patients with pineal tumors is uncertain.
  • CSF diversion (ventriculoperitoneal [VP] shunt or third ventriculostomy may be necessary in symptomatic patients, although debulking surgery may obviate the need for this procedure
  • When CSF diversion is necessary, endoscopic third ventriculostomy can be carried out at the same time as the biopsy and is preferred over VP shunts, which can be complicated by infection, shunt malfunction, subdural hematoma, and rarely, tumor seeding
Surgical resection
  • Some series report long-term survival with surgery alone, even in patients with pineoblastomas.
  • Indeed, for pineoblastomas, gross total surgical resection appears to correlate with improved survival.
  • Patients with symptomatic recurrent pineocytomas should also be considered for surgical resection of the lesion
Radiation
  • Postoperative adjuvant RT is frequently (but not universally) recommended, and local control is dose-dependent.
  • The incidence of leptomeningeal recurrence was significantly lower among patients receiving CSI compared with those who did not.
  • The five-year survival rates were 86 and 49 percent for pineocytomas and non-pineocytoma PPTs, respectively.
  • Adjuvant RT is not universally recommended after gross total resection of a pineocytoma
Stereotactic radiosurgery
  • Stereotactic radiosurgery (SRS) is emerging as a useful treatment alternative for pineocytomas, although experience is limited.
  • The precise radiation fields that are defined by MRI or CT-computerized treatment planning minimize damage to the surrounding brain, and the risks of general anesthesia and craniotomy are avoided.
  • SRS is increasingly being used to treat pineal region tumors, either as an additional therapy after conventional treatments or as a primary treatment.
  • Due to the low rate of side effects, IRS may develop into an attractive alternative to microsurgery in de novo diagnosed pineocytomas. In malignant PPTs, IRS may be routinely applied in a multimodality treatment schedule supplementary to conventional irradiation.
Chemotherapy as part of multimodality therapy
  • The similarity of pineoblastomas to medulloblastomas in terms of their clinical behavior and tendency for leptomeningeal seeding has led to the use of similar chemotherapy regimens in patients with pineoblastoma as part of a multimodality approach.
  • Chemotherapy has been used to delay radiation therapy in very young children, for whom the long-term neurocognitive and developmental side effects of craniospinal irradiation (CSI) are a major concern.
  • The importance of radiation therapy as a component of the initial treatment of supratentorial primitive neuroectodermal tumors (PNETs) is also supported by the German HIT-SKK87 and HIT-SKK92 protocols, as well as the Canadian pediatric brain tumor protocol

References

  1. ↑ Pineal yolk sac tumour. Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pineal-yolk-sac-tumour. Accessed on December 8, 2015
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF (2007). "Pineal yolk sac tumor: correlation between neuroimaging and pathological findings". Arq Neuropsiquiatr. 65 (2A): 283–5. PMID 17607429.
  3. ↑ 3.0 3.1 3.2 Tan HW, Ty A, Goh SG, Wong MC, Hong A, Chuah KL (2004). "Pineal yolk sac tumour with a solid pattern: a case report in a Chinese adult man with Down's syndrome". J Clin Pathol. 57 (8): 882–4. doi:10.1136/jcp.2004.016659. PMC 1770394. PMID 15280413.
  4. ↑ Pathology of pineal yolk sac tumour. Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pineal-yolk-sac-tumour. Accessed on December 9, 2015
  5. ↑ Associations of pineal yolk sac tumor. Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pineal-yolk-sac-tumour. Accessed on December 8, 2015


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Pineal_yolk_sac_tumor&oldid=1566161"